Loading publications…
The last 5 uploaded publications
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
Juan Carrillo-Reixach, Laura Torrens, Marina Simon‐Coma, Laura Royo, Montserrat Domingo-Sàbat, Jordi Abril‐Fornaguera, Nicholas K. Akers, María Sala, S. Ragull, Magdalena Arnal, Núria Villalmanzo, Stefano Cairo, Alberto Villanueva, Roland Kappler, Marta Garrido, Laura Guerra, Constantino Sábado, Gabriela Guillén, Mar Mallo, David Piñeyro, Maria Vázquez‐Vitali, Olga Kuchuk, María Elena Mateos, Gema Ramírez, Manuel Santamarı́a, Yasmina Mozo, Aroa Soriano, Michael Grotzer, Sophie Branchereau, Nagore García de Andoín, Blanca López‐Ibor, Ricardo López Almaraz, José Antonio Salinas, Bárbara Torres, F Hernández, José Javier Uriz, Monique Fabrè, Julià Blanco, Claudia Paris, Viera Bajčiová, Geneviève Laureys, Helena Masnou, Ariadna Clos, Cristina Beléndez, Catherine Guettier, Lauro Sumoy, Ramón Planas, Mireia Jordà, Lara Nonell, Piotr Czauderna, Bruce Morland, Daniela Sia, Bojan Losic, Marie Annick Buendia, Maria‐Rosa Sarrias, Josep M. Llovet, Carolina Armengol (2020). Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. Journal of Hepatology, 73(2), pp. 328-341, DOI: 10.1016/j.jhep.2020.03.025.
Article144 days agoEpigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer
Vanessa Ortiz-Barahona, Marta Soler, Verónica Dávalos, Carlos A. García‐Prieto, Maxime Janin, Fernando Setién, Irene Fernández-Rebollo, Joan Josep Bech‐Serra, Carolina de la Torre, Sònia Guil, Alberto Villanueva, Peihong Zhang, Li Yang, Marco Guarnacci, Ulrike Schümann, Thomas Preiß, Ugne Balaseviciute, Robert Montal, Josep M. Llovet, Manel Esteller (2023). Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer. Molecular Cancer, 22(1), DOI: 10.1186/s12943-023-01785-z.
Article144 days ago466 IGF2 drives IGF oncogenic signaling in HCC and emerges as a potential target for therapies
I.M. Quetglas, Roser Pinyol, Daniel Dauch, Anna Portela, Alberto Villanueva, Judit Peix, María Ángeles Moreno de la Higuera, Agrin Moeini, Jessica Zucman‐Rossi, Manel Esteller, Vincenzo Mazzaferro, Lars Zender, Josep M. Llovet (2014). 466 IGF2 drives IGF oncogenic signaling in HCC and emerges as a potential target for therapies. European Journal of Cancer, 50, pp. 152-152, DOI: 10.1016/s0959-8049(14)70592-1.
Article144 days agoChromatin activity of IκBα mediates the exit from naïve pluripotency
Luis G Palma, Daniel Álvarez‐Villanueva, María Maqueda, Mercedes Barrero, Arnau Iglesias, Joan Bertran, Damiana Álvarez‐Errico, Carlos A. García‐Prieto, Cecilia Ballaré, Virginia C. Rodríguez‐Cortez, Clara Bueno, August Vidal, Alberto Villanueva, Pablo Menéndez, Grégoire Stik, Luciano Di Croce, Bernhard Payer, Manel Esteller, Lluı́s Espinosa, Anna Bigas (2025). Chromatin activity of IκBα mediates the exit from naïve pluripotency. , DOI: https://doi.org/10.7554/elife.102784.1.
Preprint73 days agoChromatin activity of IκBα mediates the exit from naïve pluripotency
Luis G Palma, Daniel Álvarez‐Villanueva, María Maqueda, Mercedes Barrero, Arnau Iglesias, Joan Bertran, Damiana Álvarez‐Errico, Carlos A. García‐Prieto, Cecilia Ballaré, Virginia C. Rodríguez‐Cortez, Clara Bueno, August Vidal, Alberto Villanueva, Pablo Menéndez, Grégoire Stik, Luciano Di Croce, Bernhard Payer, Manel Esteller, Lluı́s Espinosa, Anna Bigas (2025). Chromatin activity of IκBα mediates the exit from naïve pluripotency. , DOI: https://doi.org/10.7554/elife.102784.
Preprint73 days ago